-
-
-
-
-
-
-
Rezolute (RZLT) Reiterated at Neutral by Cantor Fitzgerald After FDA Meeting
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Rezolute (RZLT)
-
-
-
-
-
-
-
Wedbush Downgrades Rezolute (RZLT) to Neutral
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
-
-
-
-
-
-
-
Rezolute (RZLT) Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
-
-
-
-
-
-
-
Rezolute Inc. (RZLT) Provides Update on its Phase 3 sunRIZE Study of Ersodetug
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Rezolute (RZLT)
-
409,072 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

